Salarius Pharmaceuticals, Inc. Share Price
SLRXSalarius Pharmaceuticals, Inc. Stock Performance
Open $0.72 | Prev. Close $0.82 | Circuit Range N/A |
Day Range $0.69 - $0.88 | Year Range $0.45 - $7.20 | Volume 21,789 |
Average Traded $0.74 |
Salarius Pharmaceuticals, Inc. Share Price Chart
About Salarius Pharmaceuticals, Inc.
Salarius Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on developing treatments for cancers with unmet medical need. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. The company also offers SP-3164, a small molecular protein degrader for the treatment of hematological and solid tumors. It has a strategic partnership with The University of Utah Research Foundation for the exclusive license with respect to patent rights protecting SP-2577 and related compounds and Cancer Prevention and Research Institute of Texas for product development activities. The company is based in Houston, Texas.
Salarius Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
07-Jan-26 | $0.72 | $0.82 | +0.00% |
07-Jan-26 | $0.72 | $0.82 | +36.65% |
06-Jan-26 | $0.53 | $0.60 | +13.77% |
05-Jan-26 | $0.57 | $0.53 | -17.45% |
31-Dec-25 | $0.64 | $0.64 | -2.58% |
26-Dec-25 | $0.64 | $0.66 | +2.01% |
24-Dec-25 | $0.65 | $0.65 | -0.77% |
FAQs on Salarius Pharmaceuticals, Inc. Share Price
Can I buy Salarius Pharmaceuticals, Inc. shares in India?
What is the share price of Salarius Pharmaceuticals, Inc.?
What is the 5 year returns of Salarius Pharmaceuticals, Inc.?
What are the high & low stock price of Salarius Pharmaceuticals, Inc. today?
What is the 52-week high and low of Salarius Pharmaceuticals, Inc. stock?